(Q43150810)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20182420%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Impact of CYP4F2 rs2108622 on the stable warfarin dose in an admixed patient cohort (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20182420%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

1 reference

Claudio José Struchiner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20182420%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Guilherme Suarez-Kurtz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20182420%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

J A Perini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20182420%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

E Silva-Assunção

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20182420%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

24 February 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20182420%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20182420%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20182420%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20182420%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

417-420

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20182420%20AND%20SRC:MED&resulttype=core&format=json

Genetic and clinical factors relating to warfarin dosing

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.307

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.307

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.307

CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.307

CYP4F2 genetic variant alters required warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.307

CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.307

Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.307

Effects of CYP4F2 genetic polymorphisms and haplotypes on clinical outcomes in patients initiated on warfarin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.307

Pharmacogenetics of warfarin: development of a dosing algorithm for brazilian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.307

Exploring warfarin pharmacogenomics with the extreme-discordant-phenotype methodology: impact of FVII polymorphisms on stable anticoagulation with warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.307

Estimation of the warfarin dose with clinical and pharmacogenetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.307

Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.307

Extreme discordant phenotype methodology: an intuitive approach to clinical pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.307

Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.307

Self-reported skin color, genomic ancestry and the distribution of GST polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.307

21 January 2018

Identifiers

DOI

10.1038/CLPT.2009.307

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20182420%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference